This report provides comprehensive information on the current therapeutic developmental pipeline of Ventria Biosciences, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/ventria-bioscience-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Ventria Bioscience - Product Pipeline Review - 2014
Ventria Bioscience - Product Pipeline Review - 2014
Summary
Global Markets Directs, Ventria Bioscience - Product Pipeline Review - 2014, provides an overview of the Ventria Biosciences pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Ventria Biosciences, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Ventria Bioscience including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ventria Biosciences human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Ventria Biosciences pipeline products
Reasons to buy
- Evaluate Ventria Biosciences strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ventria Bioscience in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ventria Biosciences R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ventria Bioscience and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ventria Bioscience
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Ventria Bioscience and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
ventria Bioscience Snapshot 5
ventria Bioscience Overview 5
key Facts 5
ventria Bioscience - Research And Development Overview 6
key Therapeutic Areas 6
ventria Bioscience - Pipeline Review 8
pipeline Products By Stage Of Development 8
pipeline Products - Monotherapy 9
ventria Bioscience - Pipeline Products Glance 10
ventria Bioscience - Late Stage Pipeline Products 10
phase Iii Products/combination Treatment Modalities 10
Ventria Bioscience - Product Pipeline Review - 2014

2. ventria Bioscience - Clinical Stage Pipeline Products 11
phase I Products/combination Treatment Modalities 11
ventria Bioscience - Early Stage Pipeline Products 12
preclinical Products/combination Treatment Modalities 12
discovery Products/combination Treatment Modalities 13
ventria Bioscience - Drug Profiles 14
talactoferrin Alfa 14
product Description 14
mechanism Of Action 14
r&d Progress 14
ven-120 16
product Description 16
mechanism Of Action 16
r&d Progress 16
ven-130 17
product Description 17
mechanism Of Action 17
r&d Progress 17
ven-140 18
product Description 18
mechanism Of Action 18
r&d Progress 18
ven-150 19
product Description 19
mechanism Of Action 19
r&d Progress 19
ven-160 20
product Description 20
mechanism Of Action 20
r&d Progress 20
ventria Bioscience - Pipeline Analysis 21
ventria Bioscience - Pipeline Products By Target 21
ventria Bioscience - Pipeline Products By Route Of Administration 22
ventria Bioscience - Pipeline Products By Molecule Type 23
ventria Bioscience - Pipeline Products By Mechanism Of Action 24
ventria Bioscience - Recent Pipeline Updates 25
ventria Bioscience - Dormant Projects 26
ventria Bioscience - Locations And Subsidiaries 27
head Office 27
other Locations & Subsidiaries 27
appendix 28
methodology 28
coverage 28
secondary Research 28
primary Research 28
expert Panel Validation 28
contact Us 29
disclaimer 29
list Of Tables
ventria Bioscience, Key Facts 5
ventria Bioscience - Pipeline By Indication, 2014 7
ventria Bioscience - Pipeline By Stage Of Development, 2014 8
ventria Bioscience - Monotherapy Products In Pipeline, 2014 9
ventria Bioscience - Phase Iii, 2014 10
ventria Bioscience - Phase I, 2014 11
ventria Bioscience - Preclinical, 2014 12
ventria Bioscience - Discovery, 2014 13
ventria Bioscience - Pipeline By Target, 2014 21
ventria Bioscience - Pipeline By Route Of Administration, 2014 22
ventria Bioscience - Pipeline By Molecule Type, 2014 23
ventria Bioscience - Pipeline Products By Mechanism Of Action, 2014 24
ventria Bioscience - Recent Pipeline Updates, 2014 25
ventria Bioscience - Dormant Developmental Projects,2014 26
ventria Bioscience, Other Locations 27
list Of Figures
ventria Bioscience - Pipeline By Top 10 Indication, 2014 7
Ventria Bioscience - Product Pipeline Review - 2014

3. ventria Bioscience - Pipeline By Stage Of Development, 2014 8
ventria Bioscience - Monotherapy Products In Pipeline, 2014 9
ventria Bioscience - Pipeline By Top 10 Target, 2014 21
ventria Bioscience - Pipeline By Top 10 Route Of Administration, 2014 22
ventria Bioscience - Pipeline By Top 10 Molecule Type, 2014 23
ventria Bioscience - Pipeline Products By Top 10 Mechanism Of Action, 2014 24
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Ventria Bioscience - Product Pipeline Review - 2014